In a new study, scientists identify some of the pitfalls when using CRISPR Cas9 to correct mutations in human embryos.
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Researchers reveal that SARS-CoV-2 is more infectious than SARS-CoV because it can use both ACE2 and neuropilin-1 to infect cells.
Some patients who develop severe COVID-19 symptoms mount ineffective immune responses due to a lack of type I interferons.
Researchers have identified two molecules that explain why children experience COVID-19 differently to adults.
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are developing new therapeutic drugs.
In human cell assays, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Thorben Seeger reveals how Genomics England's next-generation genomic research platform will play a key role in the response to COVID-19.
Researchers revealed that the antibiotic concanamycin A targets a protein called Nef, allowing the immune system to destroy HIV in cells.